Australia · Delayed Price · Currency is AUD Atlas Arteria Statistics
Total Valuation
Atlas Arteria has a market cap or net worth of AUD 6.55 billion. The enterprise value is 7.93 billion.
| Market Cap | 6.55B |
| Enterprise Value | 7.93B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Mar 25, 2026 |
Share Statistics
Atlas Arteria has 1.45 billion shares outstanding. The number of shares has increased by 0.56% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | +0.56% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 101.80% |
| Float | 1.43B |
Valuation Ratios
The trailing PE ratio is 24.40 and the forward PE ratio is 18.08. Atlas Arteria's PEG ratio is 0.35.
| PE Ratio | 24.40 |
| Forward PE | 18.08 |
| PS Ratio | 41.74 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | 78.86 |
| P/OCF Ratio | 78.67 |
| PEG Ratio | 0.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.39, with an EV/FCF ratio of 95.60.
| EV / Earnings | 29.53 |
| EV / Sales | 50.60 |
| EV / EBITDA | 25.39 |
| EV / EBIT | 32.53 |
| EV / FCF | 95.60 |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.31.
| Current Ratio | 0.75 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 53.43 |
| Debt / FCF | 19.38 |
| Interest Coverage | -0.41 |
Financial Efficiency
Return on equity (ROE) is 0.62% and return on invested capital (ROIC) is -0.47%.
| Return on Equity (ROE) | 0.62% |
| Return on Assets (ROA) | -0.32% |
| Return on Invested Capital (ROIC) | -0.47% |
| Return on Capital Employed (ROCE) | -0.56% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Atlas Arteria has paid 8.10 million in taxes.
| Income Tax | 8.10M |
| Effective Tax Rate | 18.71% |
Stock Price Statistics
The stock price has decreased by -13.60% in the last 52 weeks. The beta is 0.52, so Atlas Arteria's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -13.60% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 4.81 |
| Relative Strength Index (RSI) | 23.46 |
| Average Volume (20 Days) | 1,366,913 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Atlas Arteria had revenue of AUD 156.80 million and earned 268.70 million in profits. Earnings per share was 0.18.
| Revenue | 156.80M |
| Gross Profit | 75.60M |
| Operating Income | -38.50M |
| Pretax Income | 43.30M |
| Net Income | 268.70M |
| EBITDA | 30.10M |
| EBIT | -38.50M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 218.80 million in cash and 1.61 billion in debt, with a net cash position of -1.39 billion or -0.96 per share.
| Cash & Cash Equivalents | 218.80M |
| Total Debt | 1.61B |
| Net Cash | -1.39B |
| Net Cash Per Share | -0.96 |
| Equity (Book Value) | 5.22B |
| Book Value Per Share | 3.59 |
| Working Capital | -77.10M |
Cash Flow
In the last 12 months, operating cash flow was 83.20 million and capital expenditures -200,000, giving a free cash flow of 83.00 million.
| Operating Cash Flow | 83.20M |
| Capital Expenditures | -200,000 |
| Depreciation & Amortization | 68.60M |
| Net Borrowing | -99.80M |
| Free Cash Flow | 83.00M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 48.21%, with operating and profit margins of -24.55% and 171.36%.
| Gross Margin | 48.21% |
| Operating Margin | -24.55% |
| Pretax Margin | 27.61% |
| Profit Margin | 171.36% |
| EBITDA Margin | 19.20% |
| EBIT Margin | -24.55% |
| FCF Margin | 52.93% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 8.84%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 8.84% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 216.00% |
| Buyback Yield | -0.56% |
| Shareholder Yield | 8.28% |
| Earnings Yield | 4.11% |
| FCF Yield | 1.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Atlas Arteria is 4.78, which is 5.99% higher than the current price. The consensus rating is "Sell".
| Price Target | 4.78 |
| Price Target Difference | 5.99% |
| Analyst Consensus | Sell |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 3.07% |
| EPS Growth Forecast (3Y) | 33.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Atlas Arteria has an Altman Z-Score of 1.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 4 |